international journal of advanced pharmaceutical...
TRANSCRIPT
INTERNATIONAL JOURNAL
OF
ADVANCED PHARMACEUTICAL SCIENCES
ABSTRACT
In epilepsy,ones activity becomes disturbed that causes sensations, emotions,
behaviors and often times seizures with muscle spasms .It has shown increase
in the brain levels of GABA and Glutamate .It causes an inhibition of seizure
activity. Anticonvulsants mediate their action through alteration in various neu-
rotransmitter levels in various regions of brain .In this context screening of
aqueous extract of Pavetta indica for anticonvulsant activity is done. In this
study we took two standard methods namely PTZ and MES method. The pa-
rameters observed were the duration of tonic hind limb flexion, clonus, tonic
limb extension, and incidence and death. It was found that treatment with
EEPT on mice produces reduced tonic hind limb extensor stage in MES in-
duced epilepsy.
Keywords : MES,PTZ,EEPT
Secunderabad
PHARMACOLOGICAL STUDY OF PAVETTEA INDICA
FOR EPILEPSY IN RATS
Satyabrata Bhanja*, T Sarkar1 ,S Sahu 2
1,2Department of Pharmaceutics, Malla Reddy College of Pharmacy, Maisammaguda
Secunderabad.Andhra Pradesh.
Volume 01, Issue 01, 20-33.
Article Received on
Revised on
Accepted on
*Corresponding Author
Satyabrata Bhanja
Malla Reddy College of
Pharmacy, Maisammaguda
B.B. Karkara
* JRF,Central Drug Research Institute, Lucknow
*BB Karkara,CDRI,Lucknow,Uttar Pradesh
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 21
Introduction
Disease of CNS are major threat of the present and future .It is as a result of increase in mental stress
and strain .So a correct remedy for every CNS disorder should be found before it’s too late. we tend
to use medicines of herbal source that are having heterogeneous uses are invariably an alternate
choice to the artificial medicine .Synthetic medicine are standard for his or her adverse effects during
which the requirement isn't met.1, 2, 6, 19, 23
Now and so the prices of treating brain disorder are probably to extend given the new trends in
prescribing patterns towards newer and pricey AEDs.14 one among the newest studies within the
literature twenty five calculable that prices of prescribing costs within the community has up three-
fold within the last ten years. The prevailing medicament medicine encounter several adverse effects
and would like on prolonged treatment together with questionable effectualness within the
treatment, impairment of memory.9, 11, 15, 16 This forces the world of analysis to search out improved
treatments which is able to counteract the adverse effects and draw backs of the present treatment.37,
38
Herbal formulations still looked upon as there ar several ailments touching sizable amount of
populations left while not definite medicines. during this work I actually have tried to bring a brand
new plant for the treatment of brain disorder. during this work the medicine result of Pavetta indica,
against MES, PTZ iatrogenic convulsions were evaluated and beside in-vitro study.
The result of this plant on aminoalkane is additionally calculable to predict the potential
mechanism concerned within the treatment of those ailments. As brain monoamines except for
aminoalkanoic acid additionally plays a regulative role within the maintenance of traditional state
(McQuayet al., 1995)32
Collection and Authentication of material
Inner bark of the complete plants were dried in shade, separated and created to dry powder. it
absolutely was then more matured the 40mesh sieve for extraction purpose(Khandalwal K R
Niraliprakash1996)30
Ethanolic extracted products of Pavetta indica
A weighed amount (70gm) of the(Trease GE EVANS 1983) powder was subjected to hot solvent
extraction during a soxlet equipment mistreatment ethyl alcohol, at a temperature vary of 60-70°C.
Before and when each extraction the brandy was fully dried and weighed. The extract was targeted to
Bhanja et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 22
status at 40°C underneath reduced pressure during a rotary vacuum evaporator. The ethanolic
extracted productof Pavetta indica Linn yielded thick brown semi-solid residues.
Percentage Yield:
Percentage yield of ethanolic extracted product of Pavetta indica Linn was found to be
17.5%w/w.
Experimental Animals
Swiss unusual person mice (20-30g) of either sex were procured from Asterace labs Hyderabad,
A.P.The animals were maintained during a well-ventilated area with 12:12 hour light/dark cycle in
polypropene cages. Common place pellet feed (Hindustan Lever restricted., Bangalore) and drinkable
was provided spontaneously through out experimentation amount. Animals were acclimatized to
laboratory conditions one week before initiation of experiments. moral committee clearance was
obtained from Institutional Animal Ethics Committee (013/IAEC/StJCOP/2.012) of CPCSEA
(Committee for the aim of management and superintendence of Experiments on Animals).(Reg
no.12078/ac/09/CPCSEA)(30, 31, 35, 39)
CHEMICALS
All the Chemicals used in the study were of analytical grade the following chemicals
were used for the experimental study.
S.No. Name of the Chemicals Sources
1 5,5 Dithio-bis-2 nitrobenzoic
acid (DTNB)
S.d Fine Chemicals Ltd., Mumbai
2 Acetic Acid Sigma Chemical Cop., Mumbai
3 Acetic anhydride Sigma Chemical Cop., Mumbai
4 Chloroform Qualigens Fine Chem., Mumbai
5 Con H2SO4 Loba Chemical Pvt. Ltd. Mumbai
6 Con HCL S.d Fine Chemicals Ltd., Mumbai
Bhanja et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 23
7 DiethyleneTriaminepenta
acetic acid
S.d Fine Chemicals Ltd., Mumbai
8 Ammonia S.d Fine Chemicals Ltd., Mumbai
9 Ethanol Qualigens Fine Chem., Mumbai
10 Ethylene Diamine Tetra Acetic
acid (EDTA)
S.d Fine Chemicals Ltd., Mumbai
11 Glacial Acetic Acid S.d Fine Chemicals Ltd., Mumbai
12 Hydrogen peroxide Qualigens Fine Chem., Mumbai
13 Methanol S.d Fine Chemicals Ltd., Mumbai
14 n-butanol Qualigens Fine Chem., Mumbai
15 Neutral ferric Choride Qualigens Fine Chem., Mumbai
16 O-pthaldehyde S.d Fine Chemicals Ltd., Mumbai
17 Pentylenetetrazole Sigma Chemical Co., USA
18 Potassium Hydrogen Phosphate Qualigens Fine Chem., Mumbai
19 Potassium Hydroxide Qualigens Fine Chem., Mumbai
20 Dopamine S.d Fine Chemicals Ltd., Mumbai
21 Pyrogallol Qualigens Fine Chem., Mumbai
22 Sodium acetate S.d Fine Chemicals Ltd., Mumbai
23 Sodium bicarbonate Qualigens Fine Chem., Mumbai
24 Sodium Caboxy Methyl
Cellulose (SCMC)
Qualigens Fine Chem., Mumbai
25 Sodium Chloride S.d Fine Chemicals Ltd., Mumbai
26 Sodium dodecyl sulphate (SDS) Qualigens Fine Chem., Mumbai
27 Sodium hydroxide S.d Fine Chemicals Ltd., Mumbai
28 Sodium Sulphate S.d Fine Chemicals Ltd., Mumbai
29 Thiobarbituric acid S.d Fine Chemicals Ltd., Mumbai
30 Tricarboxylic acid Qualigens Fine Chem., Mumbai
Table No:1 Chemicals used in formulation.
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 24
Methods:
Preliminary Phytochemical Analysis 22
The extracts were subjected to preliminary phytochemical screening for the presence or absence of
phytoconstituents by the subsequent ways.
Test for Alkaloids
The extracts were treated with dilute acid and filtered. The filtrate is employed within the following
tests.
a) Mayer's Test. (Potassium metal Bromide solution)
When the extract was treated with Mayer's chemical agent and therefore the look of cream color
indicates the presence of alkaloid.
b) Dragendorffs Test. (Potassium metal Bromide solution)
When 1ml of extract was treated with the Dragendorffs chemical agent. The look of brownness
precipitate shows the presence of alkaloid.
c) Hager's Test. (Saturated solution of Picric acid)
When 1ml of extract was treated with the Hager's chemical agent. The look of yellow color
precipitate shows the presence of alkaloid.
d) Wagner's Test . (Iodine-Potassium halide solution)
When 1ml of extract was treated with the Wagner's chemical agent. the looks of brown color
precipitate shows the presence of alkaloid.
Test for Carbohydrates
a) Molisch reaction
The required extract was treated with 3ml of alpha-napthol in alcohol and targeted sulphuric acid was
extra on the perimeters of the tubing carefully. Formation of violet color ring at the junction of 2
liquids indicates the presence of carbohydrates.
b) Fehling's Test . (CuSO4.7H2O+KOH+Sodium metal Tartarate)
The required extract was treated with Fehling's solution A and B and heated in boiling water for jiffy.
The looks of reddish brown color precipitate indicates the presence of reducing sugars.
c) Benedict's Test . (Sodium Citrate+Sodium Carbonate+CuSO4.7H2O)
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 25
The required extract was treated with Benedict's chemical agent and heated during a boiling water tub
for couple of minutes. the looks of orangeness color precipitate indicates the presence of reducing
sugars.
d) Barfoed's Test . (Copper Acetate+Glacial carboxylic acid Acid)
The required extract was treated with Barfoed's chemical agent and heated during a boiling water tub
for few minutes. The looks of orangeness color precipitate indicate that non reducing sugars is
present.
Test for Steroids
Libermannburchard Test .
The required extract was treated with little amount of targeted sulphuric acid, glacial ethanoic acid
and anhydride. the looks of green color indicates the presence of steroids.
Test for Proteins
a) Biuret's Test .
The required extract was treated with copper sulfate and sodium hydroxide answer. The looks of
violet color indicates that protein is present.
b) Millon's Test . (Mercury Nitrate Solution)
The required extract was treated with Million's reagent. the looks of pink color points out that protein
is present.
Test for Tannins
a) The required extract was treated with 100% lead acetate solution. The look of white precipitate
indicates tannins.is present.
b) The required extract was treated with aqueous atomic number 35 is answer. the looks of white
precipitate indicates tannins.is present
Test for Phenols
a) The required extract was treated with neutral ferric chloride answer. the looks of violet color
indicates phenol is present
b) The required extract was treated with 100% sodium chloride solution. The look of cream color
indicates that phenols is present
Test for Flavanoids
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 26
a) About 5ml of extract was hydrolysed with 100% v/v vitriol and cooled. Then, it's extracted with
diethylether and divided into 3 parts in 3 separate Test . tubes. 1ml of diluted sodium carbonate, 1ml
of 0.1 N caustic soda, and 1ml of robust ammonia answer were extra to the primary, second and third
Test . tubes severally. In every tubing, development of yellow color demonstrated the presence of
flavanoids.
b) Shinodas Test:
The required extract was taken and dissolved in alcohol, thereto one piece of metallic element is
added followed by targeted hydrochloric acid on the perimeters of the tubing drop wise. it's heated
during a boiling water tub for few minutes. the looks of magenta color indicates the presence of
flavanoids.
Test for Flavanones
a) The required extract was treated with 100% NaOH. look of yellow to orange color shows the
presence of Flavonones.
b) The required extract was treated with Con. H2SO4 look of orange to crimson red color, confirms
that Flavones is presence
Test for Gums and Mucilage
In this test extract was treated with 25ml of absolute alcohol then product so obtained was filtered.
The filtrate was examined if it swells.
Test for Glycosides
The required extract was dissolved within the glacial acetic acid and few drops of ferric chloride
answer was extra, followed by the addition of targeted sulphuric acid, formation of red ring at the
junction of 2 liquids indicates the presence of glycosides.
Test for Saponins Foam Test.
1ml of the extract was diluted to 20ml with distilled water and jolted well during a test tube. The
formation of froth within the higher a part of the tubing indicates the presence of saponins.
Test for Terpenes
The required extract was treated with tin and thinoyl chloride, look of pink color points out the
presence of terpenes.
Test for Sterols
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 27
When the required extract was treated with five-hitter hydrated oxide solution, look of pink color
points out the presence of sterols.
Toxicological Evaluations (Acute Oral Toxicity Study)
The procedure was followed by mistreatment Organization of Economic Cooperation and
Development guide lines 423 (Acute toxicant category Method) The acute toxicant category
methodology could be a step wise procedure with 3 male animals per step. relying abreast of the
mortality and/or moribund standing of animals, on the common 2-3 steps could also be necessary to
permit judgment on the acute toxicity of the Test . substance. This procedure ends up in the
employment of smallest range of animals whereas giving acceptable information based mostly
scientific conclusion. the strategy uses outlined doses (5, 50,500,2000mg/kg body weight) and
therefore the results enable a substance to be graded and classified in keeping with the Globally
harmonical System for classification of chemicals that cause acute toxicity.
Experimental procedure
Swiss albino mice weighing 20-30g were used for the study. The beginning dose level of
S.No. Phytochemical Results
1 Test for Alkaloids +Ve
2 Test for Carbohydrates +Ve
3 Test for Proteins +Ve
4 Test for Steroids -Ve5 Test for Phenols +Ve6 Test for Flavonoids +Ve7 Test for Gums & Mucilage -Ve
8 Test for Glycosides +Ve
9 Test for Saponins -Ve
10 Test for Terpenes +Ve
11 Test for Tannis +Ve
+Ve: Indicates the presence of Compounds-Ve: Indicates the absence of Compounds
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 28
Table: 2. Preliminary Phytochemical Test for EPT
S.No. Groups Dose/
kg
b.w
Weight of
Animals
Signs of
Toxicity
Onset
Of
Toxici
ty
Duratio
n
Of study
Before After
Test1 EEPT 2000mg 25g 25g No signs of
Toxicity
Nil 14 days
2 EEPT 2000mg 25g 25g No signs of
Toxicity
Nil 14 days
3 EEPT 2000mg 25g 25g No signs of
Toxicity
Nil 14 days
Table: 3. Acute Toxicity class method OECD guidelines 423
The acute oral harmfulity study was done in keeping with OECD tips 423 (acute toxic category
method). one dose of 2000mg/kg/p.o. of the EEPT was administered three|to three} feminine mice
every and ascertained for 3 days. Animals were ascertained for signs of toxicity for initial three
hours at thirty min interval. thenceforth animals were ascertained for twenty-four hours with
continuous observation. The animals were ascertained for more fourteen days period for all toxicity
signs. There was no considerable modification in weight before and when treatment and no sign of
toxicity were ascertained. LD50 discontinue dose per kg weight was categorised as X (unclassified)
and Globally harmonical system (GHS) categories conjointly comes below X (unclassified). The
results square measure shown in (Table: 3).
Effects of EEPT on MES elicited convulsions
Phenytoin (PHT) treated animals have shown 100 percent protection against MES elicited seizures
whereas EEPT two hundred mg/kg and four hundred mg/kg have shown sixty five.20% and 70.29%
protection severally against MES elicited seizures.The EEPT at each doses and normal treated
animals had shown a big modification in period in the least stages of convulsions.EEPT two hundred
mg/kg and four hundred mg/kg had shown a big decrease within the period of tonic striated muscle
part and comparable significance (p<0.01) with the management. The results were shown in Table
3& Fig half dozen
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 29
Effect of EEPT on PTZ elicited convulsions
Diazepam treated animals have shown 100 percent protection against PTZ elicited seizures wherever
as EEPT 200 mg/kg and 400 mg/kg have shown 61.77% and 81.5% protection severally against PTZ
elicited seizures.EEPT 201 mg/kg and 440 mg/kg had shown a significant increase in onset of
convulsion convulsions and comparable (p<0.01 and p<0.01) with the control. The results were
shown in Table 4&.Mortality of EEPT 201 mg/kg and 401 mg/kg treated teams was reduced as
comparedto management cluster animals.Values are expressed as mean ±SEM of six
observationsComparison were created between: cluster I with cluster II, III and IV.Statistical
important test for comparison was done by ANOVA, followed by Dunnet’s‘t’ check.Values
expressed in seconds
EFFECT OF EEPT ON PTZ INDUCED CONVULSIONS
Group Treatment % of
Protection
Duration of
convulsion
Onset of
clonic
convulsion
% of
Protection
mortalityI CONTROL 0 72.29 ± 8.83 177.70 ± 2.36 50
II DIAZEPAM 100 10.58 ± 2.62**
765.33 ±
9.06** 100
III EEPT(200mg) 69.66 28.21 ± 3.30**
496.83 ±
3.70** 84.44
IV EEPT(400mg) 80.48 21.87 ± 1.33**
566.83 ±
5.79** 100
Table: 4 Effect of EEPT on PTZ induced convulsions
Values are expressed as mean ±SEM of six observations
Comparison were made between: Group I with Group II, III and IV
Statistical significant test for comparison was done by ANOVA, followed by Dunnet’s‘t’ test.
Values expressed in seconds
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 30
Fig 1:Effect of EEPT on PTZ indused Convulsions
Discussion:
In encephalopathy, traditional pattern of somatic cell activity becomes disturbed in brief once the
nerves within the brain “fire” ad lib inflicting sensations, emotions, behaviors and sometimes times
seizures with muscle spasms similarly as loss of consciousness (Radoset al., 2005)It has been
rumored to extend the brain levels of aminoalkanoic acid associate degreed salt that causes an
inhibition of seizure activity. (Bhaduriet al., 1995)5It is understood that anticonvulsants mediate the
action through alteration in numerous neurochemical levels in numerous regions of brain. Gamma
amino butaric acid (GABA) systems have a major role with relevancy anticonvulsive properties.
Lowering of aminoalkanoic acid in brain ends up in the looks of convulsion.In the gift study for the
screening of binary compound extract of Pavetta indica for antiepileptic drug activity, 2 normal
strategies specifically MES and PTZ strategies are used. therefore here the parameters discovered
were the length of tonic limb flexion, tonic limb extension, clonus, and incidence and death.
MES methodology contains a high degree of productivity for medicine helpful within the
management of tonic convulsion seizures. And for PTZ elicited seizures showing convulsive response
were used for the experiment (Rolaet al., 2002)It is found that treatment with EEPT on mice
considerably reduces in tonic limb skeletal muscle stage in MES elicited encephalopathy. finally, we
recommend that ethanolic extracted product of Pavetta indica Linn. markedly protects
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 31
encephalopathy elicited by MES and PTZ that are mediate by levels of monoamines and inhibitor
enzymes. more studies are needed to isolate and characterize numerous phytoconstituents to
determine the impact on numerous varieties of encephalopathy like generalized seizure, petit mal,
absence and partial seizure.
Conclusion
The preliminary phytochemical screening of EEPT shows presence of assorted chemistry constituents
like alkaloids, carbohydrates, proteins, sterols, polyphenolic compounds and gums etc. The
anticonvulsant drug activity of EEPT was assessed by MES elicited convulsion and PTZ elicited
convulsion that it showed significant attenuative.In MES elicited encephalopathy, EEPT at each
200mg/kg and 400mg/kg exhibits important anticonvulsant drug activity significantly tonic limb
skeletal muscle stage.In PTZ elicited encephalopathy, EEPT at each 200mg/kg and 400mg/kg
exhibits important anticonvulsant drug activity and delayed the onset of convulsions and cut back the
length of convulsion. Pavetta indicaLinn could be a renowned plant that is getting used in Indian
ancient Medicines for encephalopathy and central nervous system associated disorders. therefore this
analysis is expressed to form the evident impact of the complete plant inner bark on
encephalopathy.The investigation is on disbursed on each in vivo and in vitro model like MES and
PTZ elicited convulsion In MES and PTZ elicited encephalopathy, EEPT at each 200mg and 400mg
exhibited considerably anticonvulsant drug activity. finally from the observation, it may be envisaged,
the anticonvulsant drug activity of Pavetta indica Linn. more studies are needed to isolate and
charecterised numerous phytoconstituents and to determine the impact of assorted varieties of
encephalopathy like generalized seizure, petit mal, absence and partial seizure.
REFERENCES
1. Adhikarla S. Root flavanoids. Bot Rev 1984; 56: 29-37
2. Agosta W. Medicines and Drugs from Plants. Journal of Chemical Education 1997; 74:857.
3. Balakrishnan S, Pandhi P, Bhargava VK. Effects of nimodipine on the efficacy of commonly
used antiepileptic drugs in mice. Ind j expBiol 1998; 36: 51-5
4. Beauchamp C, Fridovich I. Superoxide dismutase improved assay and an assay applicable to
acrylamide gels. Annals Biochem. 1971; 44: 276–287
5. Bhaduri J, Hota D, Acharya SB. Role of prostaglandin synthesis inhibitor on chemically
induced seizure. Ind J ExpBiol 1995; 33:677-681.
6. Bienvenu E, Amabeoku GJ, Eagles PK, Scott G, Springfield EP. Anticonvulsant activity of
aqueous extract of Leonotisleonurus. Phytomedicine 2002; 9(3): 217-223
7. Blumer D. Evidence supporting the temporal lobe epilepsy personality syndrome. Neurology
1999; 53:9–12.
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 32
8. Brandt HD, Osuch E, Mathibe L&Tsipa P. Plants associated with accidental poisoned
patients presenting at Ga-RankuwaHospital. Pretoria: Suid-
AfrikaanseTyskrifvirwetenskap1995;9: 57-59.
9. Benbadis SR & Tatum WO. Advances in the treatment of epilepsy. Am FamPhysician
2001;64(1): 91-98.
10. Brodie MJ, Lerche H, Gil-Nagel A, Elger C, Hall S, Shin P, Nohria V, Mansbach H.
RESTORE 2 Study Group. Efficacy and safety of ezogabine (retigabine) in refractory partial
epilepsy. Neurology 2010; 75:1817–1824.
11. Commission on Classification and Terminology of the International League Against
Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic
seizures. Epilepsia 1981; 22: 489–501.
12. DoblerRE,Anderson BM. simultaneous inactivation of the catalytic activities of yeast
glutathione reductase by N-alkyl melimides, Biochem. Biophys. Acta1981;9:70-65
13. Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel 2 ligands novel modulators of
neurotransmission. Trends PharmacolSci2007; 28: 75-82.
14. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA. Epilepsy and mortality in Africa a
review of the literature. Epilepsia2005;46: 33-35.
15. Elger CE. Future trends in epileptology. CurrOpin Neurol. 2001;14:185–186.
16. Engelborghs S, Hooge RD, De Deyn PP, Pathophysiology of epilepsy. Acta neurol. Belg
2000; 10:201-213
17. Fisher JL. The anticonvulsant stiripenol acts directlyon the GABAA receptor as a
positive alloseric modulator. Neuropharmocology 2008; 54:954-964
18. Foster JG, Hess JL. Responses of superoxide dismutase and glutathione reductase activities
in cotton leaf tissue exposed to an atmosphere enriched in oxygen. Plant Physiol. 1980; 66:
482–487
19. Govender S, Plessis-Stoman D, Downing TG & Van de Venter M. Traditional herbal
medicines: microbial contamination. Consumer safety and the need for standards. South
African Journal of Science 2006; 102: 253-255.
20. George J & Van StadenJ. Intellectual property rights. Plants andPhytomedicinals Past
history. Present scenario and Future prospects in South Africa. South African Journal of
Science 2000; 96: 433-442.
21. Goodman GA, Hardman JG, Limbird LE. The Pharmocological Basis of Therapeutic.
McGraw-Hill medical publishing division 10th edition 2001; 56:302-311
22. Harbone JP, Phytochemical methods. A GUIDE to modern technique of plant analysis
(Chapmann and Hall) 1973; 1-21.
et al. INTERNATIONAL JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCES
www.ijaps.net Page 33
23. Hartwell JL. Plants used against epilepsy. A survey: Lloydia. 1971; 34: 30-34
24. Hauser WA, Engel J and Pedley T A. Epilepsy A comprehensive Textbook, Lippincoot
Raven 1997; 47.
25. Hauser WA, Hesdorffer DC. Epilepsy: Frequency, Causes and Consequences. Demos1990.
26. Hill MW, Reddy PA, Covey DF, Rothman SM. Contribution of sub saturating GABA
concentrations to IPSCs in cultured hippocampal neurons. J Neurosci1998;14: 5103-5111.
27. Hodges DM, Delong JM, Forney CF, Prange RK. Improving the thiobarbituric acid-
reactivesubstances assay for estimating lipid peroxidation in plant tissues containing
anthocyanin and other interfering compounds. Planta1999; 207: 604-611.
28. Isokawa M. Decrement of GABAA receptor-mediated inhibitory postsynaptic currents
in dentate granule cells in epileptic hippocampus. J Neurophysiol1996; 5: 1901-1908.
29. Kang TC, Kang JH, Kim HT, Lee SJ, Choi UK, Kim JE. Anticonvulsant characteristics of
pyrioxyl-g-aminobutyrate PL-GABA. Neuropharmocology 2008; 54:954-964
30. Khandalwal KR. Practical pharmocognosy techniques and experiments. 3rd ed. Pune
Niraliprakash 1996.
31. Krauss GL, MATHEWS GC. How animal models can be used to understand and treat
epilepsy
32. Kulkarni SK. Hand Book of Experimental Pharmacology. Vallab Prakashan 1993; 78.
33. KuoCC, and LL. Characterization o f lamotrigine inhibition of Naþ channels in rat
hippocampal neurones. Br. J. Pharmacology. 1997; 121: 1231–1238.
34. Larson AA and Beitz AJ. Glycine potentiates strychnine-induced convulsions role of NMDA
Receptors. The journal of neuroscience 1988; 810
35. Loscher. W Animal models of epilepsy for the development of antiepileptogenic and
disease-modifying drugs. A comparison of the pharmacology of kindling and post-status
epilepticus models of temporal lobe epilepsy. Epilepsy Res 2002;1-2: 105-123
36. Mc. Donald RL and Kelly KM. Antiepileptic drugs: Mechanism of action. Epilespsia. 1991;
34: 51-58.
37. McCabe PH. New anti-epileptic drugs for the 21st century. Expert
Opin Pharmacother20001(4): 633-674.
38. Mattson RH. Efficacy and adverse effects of established and new antiepileptic drugs.
Epilepsia1995; 2:S13-26.
39. McKinney W T , Jr Bunney WE. Animal model of depression. Review of evidence
implications for research. Arch Gen Psychiatry 1969; 21(2): 240-248.1052.
40.McQuay H, Carroll D, Jadad AR, et al. Anticonvulsant drugs for management of pain: a
systematic review BMJ Clinical Research 1995; 311(7012):1047-52